ReP USP - Resultado da busca

Artigo de periodico
MSI2 expression in adrenocortical carcinoma: Association with unfavorable prognosis and correlation with steroid and immune‐related pathways (2021)
Veronez, Luciana Chain ; Chagas, Pablo F. das; Correa, Carolina Alves Pereira ; Baroni, Mirella; Silva, Keteryne Rodrigues da ; Nagano, Luís Fernando Peinado ; Borges, Kleiton S; Queiroz, Rosane Gomes de Paula; Tone, Luiz Gonzaga ; Scrideli, Carlos Alberto
Source: Journal of Cellular Biochemistry. Unidades: FMRP, FCFRP
Subjects: NEOPLASIAS, CARCINOMA, CÓRTEX ADRENAL, BIOMARCADORES, REGULAÇÃO NEOPLÁSICA DA EXPRESSÃO GÊNICA, ESTEROIDES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VERONEZ, Luciana Chain et al. MSI2 expression in adrenocortical carcinoma: Association with unfavorable prognosis and correlation with steroid and immune‐related pathways. Journal of Cellular Biochemistry, v. 122, n. 12, p. 1925-1935, 2021Tradução . . Disponível em: https://doi.org/10.1002/jcb.30153. Acesso em: 13 nov. 2024.
APA
Veronez, L. C., Chagas, P. F. das, Correa, C. A. P., Baroni, M., Silva, K. R. da, Nagano, L. F. P., et al. (2021). MSI2 expression in adrenocortical carcinoma: Association with unfavorable prognosis and correlation with steroid and immune‐related pathways. Journal of Cellular Biochemistry, 122( 12), 1925-1935. doi:10.1002/jcb.30153
NLM
Veronez LC, Chagas PF das, Correa CAP, Baroni M, Silva KR da, Nagano LFP, Borges KS, Queiroz RG de P, Tone LG, Scrideli CA. MSI2 expression in adrenocortical carcinoma: Association with unfavorable prognosis and correlation with steroid and immune‐related pathways [Internet]. Journal of Cellular Biochemistry. 2021 ; 122( 12): 1925-1935.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1002/jcb.30153
Vancouver
Veronez LC, Chagas PF das, Correa CAP, Baroni M, Silva KR da, Nagano LFP, Borges KS, Queiroz RG de P, Tone LG, Scrideli CA. MSI2 expression in adrenocortical carcinoma: Association with unfavorable prognosis and correlation with steroid and immune‐related pathways [Internet]. Journal of Cellular Biochemistry. 2021 ; 122( 12): 1925-1935.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1002/jcb.30153
Artigo de periodico
Ultraconserved long non-coding RNA uc.112 is highly expressed in childhood T versus B-cell acute lymphoblastic leukemia (2021)
Chagas, Pablo Ferreira das ; Sousa, Graziella Ribeiro de ; Kodama, Márcio Hideki; Biagi Junior, Carlos Alberto Oliveira de ; Yunes, Jose Andres ; Brandalise, Silvia Regina; Calin, George Adrian; Tone, Luiz Gonzaga ; Scrideli, Carlos Alberto ; Oliveira, Jaqueline Carvalho de
Source: Hematology, Transfusion and Cell Therapy. Unidade: FMRP
Subjects: RNA, LEUCEMIA, LINFOMA, CÉLULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHAGAS, Pablo Ferreira das et al. Ultraconserved long non-coding RNA uc.112 is highly expressed in childhood T versus B-cell acute lymphoblastic leukemia. Hematology, Transfusion and Cell Therapy, v. 43, n. 1, p. 28-34, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.htct.2019.12.003. Acesso em: 13 nov. 2024.
APA
Chagas, P. F. das, Sousa, G. R. de, Kodama, M. H., Biagi Junior, C. A. O. de, Yunes, J. A., Brandalise, S. R., et al. (2021). Ultraconserved long non-coding RNA uc.112 is highly expressed in childhood T versus B-cell acute lymphoblastic leukemia. Hematology, Transfusion and Cell Therapy, 43( 1), 28-34. doi:10.1016/j.htct.2019.12.003
NLM
Chagas PF das, Sousa GR de, Kodama MH, Biagi Junior CAO de, Yunes JA, Brandalise SR, Calin GA, Tone LG, Scrideli CA, Oliveira JC de. Ultraconserved long non-coding RNA uc.112 is highly expressed in childhood T versus B-cell acute lymphoblastic leukemia [Internet]. Hematology, Transfusion and Cell Therapy. 2021 ; 43( 1): 28-34.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.htct.2019.12.003
Vancouver
Chagas PF das, Sousa GR de, Kodama MH, Biagi Junior CAO de, Yunes JA, Brandalise SR, Calin GA, Tone LG, Scrideli CA, Oliveira JC de. Ultraconserved long non-coding RNA uc.112 is highly expressed in childhood T versus B-cell acute lymphoblastic leukemia [Internet]. Hematology, Transfusion and Cell Therapy. 2021 ; 43( 1): 28-34.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.htct.2019.12.003
Artigo de periodico-carta/editorial
Short-term response to alemtuzumab in CD52-positive secondary histiocytic sarcoma in a child. [Carta]: Is it time to consider new targets? (2020)
Valera, Elvis Terci; Brassesco, Maria Sol ; Reis, Maristella Bergamo Francisco dos; Maggioni, Gilberto; Guerino-Cunha, Renato Luiz; Grecco, Carlos Eduardo; Elias Júnior, Jorge ; Kato, Mery; Tone, Luiz Gonzaga
Source: Pediatric Hematology and Oncology. Unidades: FMRP, FFCLRP
Subjects: ANTICORPOS MONOCLONAIS, HISTIOCITOSE, NEOPLASIAS POR TIPO HISTOLÓGICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VALERA, Elvis Terci et al. Short-term response to alemtuzumab in CD52-positive secondary histiocytic sarcoma in a child. [Carta]: Is it time to consider new targets?. Pediatric Hematology and Oncology. Abingdon: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1080/08880018.2020.1811438. Acesso em: 13 nov. 2024. , 2020
APA
Valera, E. T., Brassesco, M. S., Reis, M. B. F. dos, Maggioni, G., Guerino-Cunha, R. L., Grecco, C. E., et al. (2020). Short-term response to alemtuzumab in CD52-positive secondary histiocytic sarcoma in a child. [Carta]: Is it time to consider new targets? Pediatric Hematology and Oncology. Abingdon: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1080/08880018.2020.1811438
NLM
Valera ET, Brassesco MS, Reis MBF dos, Maggioni G, Guerino-Cunha RL, Grecco CE, Elias Júnior J, Kato M, Tone LG. Short-term response to alemtuzumab in CD52-positive secondary histiocytic sarcoma in a child. [Carta]: Is it time to consider new targets? [Internet]. Pediatric Hematology and Oncology. 2020 ; 38( 1): 89-96.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1080/08880018.2020.1811438
Vancouver
Valera ET, Brassesco MS, Reis MBF dos, Maggioni G, Guerino-Cunha RL, Grecco CE, Elias Júnior J, Kato M, Tone LG. Short-term response to alemtuzumab in CD52-positive secondary histiocytic sarcoma in a child. [Carta]: Is it time to consider new targets? [Internet]. Pediatric Hematology and Oncology. 2020 ; 38( 1): 89-96.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1080/08880018.2020.1811438
Artigo de periodico
MicroRNA profile of pediatric pilocytic astrocytomas identifies two tumor-specific signatures when compared to non-neoplastic white matter (2019)
Darrigo Júnior, Luiz Guilherme ; Lira, Régia Caroline Peixoto ; Fedatto, Paola Fernanda ; Marco Antonio, David Santos ; Valera, Elvis Terci ; Aguiar, Simone; Yunes, Jose Andres ; Brandalise, Silvia Regina; Neder, Luciano ; Saggioro, Fabiano Pinto ; Becker, Aline Paixão ; Oliveira, Ricardo Santos de; Machado, Hélio Rubens; Panepucci, Rodrigo Alexandre ; Tone, Luiz Gonzaga ; Scrideli, Carlos Alberto
Source: Journal of Neuro-Oncology. Unidades: FMRP, SVOI
Subjects: NEUROFIBROMATOSES, ASTROCITOMA, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DARRIGO JÚNIOR, Luiz Guilherme et al. MicroRNA profile of pediatric pilocytic astrocytomas identifies two tumor-specific signatures when compared to non-neoplastic white matter. Journal of Neuro-Oncology, v. 141, n. 2, p. 373-382, 2019Tradução . . Disponível em: https://doi.org/10.1007/s11060-018-03042-6. Acesso em: 13 nov. 2024.
APA
Darrigo Júnior, L. G., Lira, R. C. P., Fedatto, P. F., Marco Antonio, D. S., Valera, E. T., Aguiar, S., et al. (2019). MicroRNA profile of pediatric pilocytic astrocytomas identifies two tumor-specific signatures when compared to non-neoplastic white matter. Journal of Neuro-Oncology, 141( 2), 373-382. doi:10.1007/s11060-018-03042-6
NLM
Darrigo Júnior LG, Lira RCP, Fedatto PF, Marco Antonio DS, Valera ET, Aguiar S, Yunes JA, Brandalise SR, Neder L, Saggioro FP, Becker AP, Oliveira RS de, Machado HR, Panepucci RA, Tone LG, Scrideli CA. MicroRNA profile of pediatric pilocytic astrocytomas identifies two tumor-specific signatures when compared to non-neoplastic white matter [Internet]. Journal of Neuro-Oncology. 2019 ; 141( 2): 373-382.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1007/s11060-018-03042-6
Vancouver
Darrigo Júnior LG, Lira RCP, Fedatto PF, Marco Antonio DS, Valera ET, Aguiar S, Yunes JA, Brandalise SR, Neder L, Saggioro FP, Becker AP, Oliveira RS de, Machado HR, Panepucci RA, Tone LG, Scrideli CA. MicroRNA profile of pediatric pilocytic astrocytomas identifies two tumor-specific signatures when compared to non-neoplastic white matter [Internet]. Journal of Neuro-Oncology. 2019 ; 141( 2): 373-382.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1007/s11060-018-03042-6
Artigo de periodico
Prognostic value and functional role of ROCK2 in pediatric Ewing sarcoma (2018)
Vieira, Gabriela Maciel ; Roberto, Gabriela Molinari; Lira, Régia Caroline ; Engel, Edgard Eduard ; Tone, Luiz Gonzaga ; Annichini, María Sol Brassesco
Source: Oncology Letters. Unidades: FMRP, FFCLRP
Subjects: SARCOMA DE EWING, EXPRESSÃO GÊNICA, PROTEÍNAS QUINASES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIEIRA, Gabriela Maciel et al. Prognostic value and functional role of ROCK2 in pediatric Ewing sarcoma. Oncology Letters, v. 15, n. 2, p. 2296-2304, 2018Tradução . . Disponível em: https://doi.org/10.3892/ol.2017.7571. Acesso em: 13 nov. 2024.
APA
Vieira, G. M., Roberto, G. M., Lira, R. C., Engel, E. E., Tone, L. G., & Annichini, M. S. B. (2018). Prognostic value and functional role of ROCK2 in pediatric Ewing sarcoma. Oncology Letters, 15( 2), 2296-2304. doi:10.3892/ol.2017.7571
NLM
Vieira GM, Roberto GM, Lira RC, Engel EE, Tone LG, Annichini MSB. Prognostic value and functional role of ROCK2 in pediatric Ewing sarcoma [Internet]. Oncology Letters. 2018 ; 15( 2): 2296-2304.[citado 2024 nov. 13 ] Available from: https://doi.org/10.3892/ol.2017.7571
Vancouver
Vieira GM, Roberto GM, Lira RC, Engel EE, Tone LG, Annichini MSB. Prognostic value and functional role of ROCK2 in pediatric Ewing sarcoma [Internet]. Oncology Letters. 2018 ; 15( 2): 2296-2304.[citado 2024 nov. 13 ] Available from: https://doi.org/10.3892/ol.2017.7571
Artigo de periodico
Molecular characterization of Wnt pathway and function of β-catenin overexpression in medulloblastoma cell lines (2018)
Geron, Lenisa; Salomão, Karina Bezerra; Borges, Kleiton Silva; Andrade, Augusto Faria; Corrêa, Carolina Alves Pereira; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga
Source: Cytotechnology. Unidade: FMRP
Assunto: MEDULOBLASTOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GERON, Lenisa et al. Molecular characterization of Wnt pathway and function of β-catenin overexpression in medulloblastoma cell lines. Cytotechnology, v. 70, n. 6, p. 1713-1722, 2018Tradução . . Disponível em: https://doi.org/10.1007/s10616-018-0260-2. Acesso em: 13 nov. 2024.
APA
Geron, L., Salomão, K. B., Borges, K. S., Andrade, A. F., Corrêa, C. A. P., Scrideli, C. A., & Tone, L. G. (2018). Molecular characterization of Wnt pathway and function of β-catenin overexpression in medulloblastoma cell lines. Cytotechnology, 70( 6), 1713-1722. doi:10.1007/s10616-018-0260-2
NLM
Geron L, Salomão KB, Borges KS, Andrade AF, Corrêa CAP, Scrideli CA, Tone LG. Molecular characterization of Wnt pathway and function of β-catenin overexpression in medulloblastoma cell lines [Internet]. Cytotechnology. 2018 ; 70( 6): 1713-1722.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1007/s10616-018-0260-2
Vancouver
Geron L, Salomão KB, Borges KS, Andrade AF, Corrêa CAP, Scrideli CA, Tone LG. Molecular characterization of Wnt pathway and function of β-catenin overexpression in medulloblastoma cell lines [Internet]. Cytotechnology. 2018 ; 70( 6): 1713-1722.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1007/s10616-018-0260-2
Artigo de periodico
HIF1A is overexpressed in medulloblastoma and its inhibition reduces proliferation and increases EPAS1 and ATG16L1 methylation (2018)
Cruzeiro, Gustavo Alencastro Veiga; Reis, Maristella Bergamo dos; Silveira, Vanessa da Silva; Lira, Regia Caroline Peixoto; Carlotti Júnior, Carlos Gilberto; Neder, Luciano; Oliveira, Ricardo Santos; Yunes, Jose Andres; Brandalise, Silvia Regina; Aguiar, Simone; Eterovic, Agda Karina; Tone, Luiz Gonzaga; Scrideli, Carlos Alberto; Valera, Elvis Terci
Source: Current Cancer Drug Targets. Unidade: FMRP
Subjects: MEDULOBLASTOMA, ANÓXIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRUZEIRO, Gustavo Alencastro Veiga et al. HIF1A is overexpressed in medulloblastoma and its inhibition reduces proliferation and increases EPAS1 and ATG16L1 methylation. Current Cancer Drug Targets, v. 18, n. 3, p. 287-294, 2018Tradução . . Disponível em: https://doi.org/10.2174/1568009617666170315162525. Acesso em: 13 nov. 2024.
APA
Cruzeiro, G. A. V., Reis, M. B. dos, Silveira, V. da S., Lira, R. C. P., Carlotti Júnior, C. G., Neder, L., et al. (2018). HIF1A is overexpressed in medulloblastoma and its inhibition reduces proliferation and increases EPAS1 and ATG16L1 methylation. Current Cancer Drug Targets, 18( 3), 287-294. doi:10.2174/1568009617666170315162525
NLM
Cruzeiro GAV, Reis MB dos, Silveira V da S, Lira RCP, Carlotti Júnior CG, Neder L, Oliveira RS, Yunes JA, Brandalise SR, Aguiar S, Eterovic AK, Tone LG, Scrideli CA, Valera ET. HIF1A is overexpressed in medulloblastoma and its inhibition reduces proliferation and increases EPAS1 and ATG16L1 methylation [Internet]. Current Cancer Drug Targets. 2018 ; 18( 3): 287-294.[citado 2024 nov. 13 ] Available from: https://doi.org/10.2174/1568009617666170315162525
Vancouver
Cruzeiro GAV, Reis MB dos, Silveira V da S, Lira RCP, Carlotti Júnior CG, Neder L, Oliveira RS, Yunes JA, Brandalise SR, Aguiar S, Eterovic AK, Tone LG, Scrideli CA, Valera ET. HIF1A is overexpressed in medulloblastoma and its inhibition reduces proliferation and increases EPAS1 and ATG16L1 methylation [Internet]. Current Cancer Drug Targets. 2018 ; 18( 3): 287-294.[citado 2024 nov. 13 ] Available from: https://doi.org/10.2174/1568009617666170315162525
Artigo de periodico
Downregulation of miR-10B* is correlated with altered expression of mitotic kinases in osteosarcoma (2018)
Roberto, Gabriela Molinari; Engel, Edgard Eduard; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga; Brassesco, Maria Sol
Source: Pathology - Research and Practice. Unidades: FMRP, FFCLRP
Assunto: OSTEOSSARCOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROBERTO, Gabriela Molinari et al. Downregulation of miR-10B* is correlated with altered expression of mitotic kinases in osteosarcoma. Pathology - Research and Practice, v. 214, n. 2, p. 213-216, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.prp.2017.11.020. Acesso em: 13 nov. 2024.
APA
Roberto, G. M., Engel, E. E., Scrideli, C. A., Tone, L. G., & Brassesco, M. S. (2018). Downregulation of miR-10B* is correlated with altered expression of mitotic kinases in osteosarcoma. Pathology - Research and Practice, 214( 2), 213-216. doi:10.1016/j.prp.2017.11.020
NLM
Roberto GM, Engel EE, Scrideli CA, Tone LG, Brassesco MS. Downregulation of miR-10B* is correlated with altered expression of mitotic kinases in osteosarcoma [Internet]. Pathology - Research and Practice. 2018 ; 214( 2): 213-216.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.prp.2017.11.020
Vancouver
Roberto GM, Engel EE, Scrideli CA, Tone LG, Brassesco MS. Downregulation of miR-10B* is correlated with altered expression of mitotic kinases in osteosarcoma [Internet]. Pathology - Research and Practice. 2018 ; 214( 2): 213-216.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.prp.2017.11.020
Artigo de periodico
A new complex rearrangement in infant ALL: t(X;11;17)(p11.2;q23;q12) (2018)
Brassesco, Maria Sol; Valera, Elvis Terci; Meyer, Claus; Marschalek, Rolf; Lopes, Bruno Almeida; Queiroz, Rosane Gomes de Paula; Calado, Rodrigo Tocantins; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga
Source: Cancer Genetics. Unidades: FMRP, FFCLRP
Subjects: LEUCEMIA, PEDIATRIA, CITOGENÉTICA, CROMOSSOMO X
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRASSESCO, Maria Sol et al. A new complex rearrangement in infant ALL: t(X;11;17)(p11.2;q23;q12). Cancer Genetics, v. 228-229, p. 110-114, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.cancergen.2018.10.006. Acesso em: 13 nov. 2024.
APA
Brassesco, M. S., Valera, E. T., Meyer, C., Marschalek, R., Lopes, B. A., Queiroz, R. G. de P., et al. (2018). A new complex rearrangement in infant ALL: t(X;11;17)(p11.2;q23;q12). Cancer Genetics, 228-229, 110-114. doi:10.1016/j.cancergen.2018.10.006
NLM
Brassesco MS, Valera ET, Meyer C, Marschalek R, Lopes BA, Queiroz RG de P, Calado RT, Scrideli CA, Tone LG. A new complex rearrangement in infant ALL: t(X;11;17)(p11.2;q23;q12) [Internet]. Cancer Genetics. 2018 ; 228-229 110-114.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.cancergen.2018.10.006
Vancouver
Brassesco MS, Valera ET, Meyer C, Marschalek R, Lopes BA, Queiroz RG de P, Calado RT, Scrideli CA, Tone LG. A new complex rearrangement in infant ALL: t(X;11;17)(p11.2;q23;q12) [Internet]. Cancer Genetics. 2018 ; 228-229 110-114.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.cancergen.2018.10.006
Artigo de periodico
Neuroimaging findings in Mowat–Wilson syndrome: a study of 54 patients (2017)
Garavelli, Livia; Ivanovski, Ivan; Caraffi, Stefano Giuseppe; Santodirocco, Daniela; Pollazzon, Marzia; Cordelli, Duccio Maria; Abdalla, Ebtesam; Accorsi, Patrizia; Adam, Margaret P.; Baldo, Chiara; Bayat, Allan; Belligni, Elga; Bonvicini, Federico; Breckpot, Jeroen; Callewaert, Bert; Cocchi, Guido; Cuturilo, Goran; Devriendt, Koenraad; Dinulos, Mary Beth; Djuric, Olivera; Epifanio, Roberta; Faravelli, Francesca; Formisano, Debora; Giordano, Lucio; Grasso, Marina; Grønborg, Sabine; Iodice, Alessandro; Iughetti, Lorenzo; Lacombe, Didier; Maggi, Massimo; Malbora, Baris; Mammi, Isabella; Moutton, Sebastien; Møller, Rikke; Muschke, Petra; Napoli, Manuela; Pantaleoni, Chiara; Pascarella, Rosario; Pellicciari, Alessandro; Poch-Olive, Maria Luisa; Raviglione, Federico; Rivieri, Francesca; Russo, Carmela; Savasta, Salvatore; Scarano, Gioacchino; Selicorni, Angelo; Silengo, Margherita; Sorge, Giovanni; Tarani, Luigi; Tone, Luiz Gonzaga; Toutain, Annick; Trimouille, Aurelien; Valera, Elvis Terci; Vergano, Samantha Schrier; Zanotta, Nicoletta; Zollino, Marcella; Dobyns, William B; Paciorkowski, Alex R
Source: Genetics in Medicine. Unidade: FMRP
Subjects: DOENÇAS GENÉTICAS, MALFORMAÇÕES, NEUROIMAGEM
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GARAVELLI, Livia et al. Neuroimaging findings in Mowat–Wilson syndrome: a study of 54 patients. Genetics in Medicine, v. 19, n. 6, p. 691-700, 2017Tradução . . Disponível em: https://doi.org/10.1038/gim.2016.176. Acesso em: 13 nov. 2024.
APA
Garavelli, L., Ivanovski, I., Caraffi, S. G., Santodirocco, D., Pollazzon, M., Cordelli, D. M., et al. (2017). Neuroimaging findings in Mowat–Wilson syndrome: a study of 54 patients. Genetics in Medicine, 19( 6), 691-700. doi:10.1038/gim.2016.176
NLM
Garavelli L, Ivanovski I, Caraffi SG, Santodirocco D, Pollazzon M, Cordelli DM, Abdalla E, Accorsi P, Adam MP, Baldo C, Bayat A, Belligni E, Bonvicini F, Breckpot J, Callewaert B, Cocchi G, Cuturilo G, Devriendt K, Dinulos MB, Djuric O, Epifanio R, Faravelli F, Formisano D, Giordano L, Grasso M, Grønborg S, Iodice A, Iughetti L, Lacombe D, Maggi M, Malbora B, Mammi I, Moutton S, Møller R, Muschke P, Napoli M, Pantaleoni C, Pascarella R, Pellicciari A, Poch-Olive ML, Raviglione F, Rivieri F, Russo C, Savasta S, Scarano G, Selicorni A, Silengo M, Sorge G, Tarani L, Tone LG, Toutain A, Trimouille A, Valera ET, Vergano SS, Zanotta N, Zollino M, Dobyns WB, Paciorkowski AR. Neuroimaging findings in Mowat–Wilson syndrome: a study of 54 patients [Internet]. Genetics in Medicine. 2017 ; 19( 6): 691-700.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1038/gim.2016.176
Vancouver
Garavelli L, Ivanovski I, Caraffi SG, Santodirocco D, Pollazzon M, Cordelli DM, Abdalla E, Accorsi P, Adam MP, Baldo C, Bayat A, Belligni E, Bonvicini F, Breckpot J, Callewaert B, Cocchi G, Cuturilo G, Devriendt K, Dinulos MB, Djuric O, Epifanio R, Faravelli F, Formisano D, Giordano L, Grasso M, Grønborg S, Iodice A, Iughetti L, Lacombe D, Maggi M, Malbora B, Mammi I, Moutton S, Møller R, Muschke P, Napoli M, Pantaleoni C, Pascarella R, Pellicciari A, Poch-Olive ML, Raviglione F, Rivieri F, Russo C, Savasta S, Scarano G, Selicorni A, Silengo M, Sorge G, Tarani L, Tone LG, Toutain A, Trimouille A, Valera ET, Vergano SS, Zanotta N, Zollino M, Dobyns WB, Paciorkowski AR. Neuroimaging findings in Mowat–Wilson syndrome: a study of 54 patients [Internet]. Genetics in Medicine. 2017 ; 19( 6): 691-700.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1038/gim.2016.176
Artigo de periodico
The aurora kinase inhibitor AMG 900 increases apoptosis and induces chemosensitivity to anticancer drugs in the NCI-H295 adrenocortical carcinoma cell line (2017)
Borges, Kleiton S.; Andrade, Augusto F.; Silveira, Vanessa da Silva; Marco Antonio, David S.; Vasconcelos, Elton J.R.; Antonini, Sonir Roberto Rauber; Tone, Luiz Gonzaga; Scrideli, Carlos Alberto
Source: Anti-Cancer Drugs. Unidade: FMRP
Subjects: APOPTOSE, FÁRMACOS, ANTINEOPLÁSICOS, CARCINOMA, SOBREVIDA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORGES, Kleiton S. et al. The aurora kinase inhibitor AMG 900 increases apoptosis and induces chemosensitivity to anticancer drugs in the NCI-H295 adrenocortical carcinoma cell line. Anti-Cancer Drugs, v. 28, n. 6, p. 634-644, 2017Tradução . . Disponível em: https://doi.org/10.1097/cad.0000000000000504. Acesso em: 13 nov. 2024.
APA
Borges, K. S., Andrade, A. F., Silveira, V. da S., Marco Antonio, D. S., Vasconcelos, E. J. R., Antonini, S. R. R., et al. (2017). The aurora kinase inhibitor AMG 900 increases apoptosis and induces chemosensitivity to anticancer drugs in the NCI-H295 adrenocortical carcinoma cell line. Anti-Cancer Drugs, 28( 6), 634-644. doi:10.1097/cad.0000000000000504
NLM
Borges KS, Andrade AF, Silveira V da S, Marco Antonio DS, Vasconcelos EJR, Antonini SRR, Tone LG, Scrideli CA. The aurora kinase inhibitor AMG 900 increases apoptosis and induces chemosensitivity to anticancer drugs in the NCI-H295 adrenocortical carcinoma cell line [Internet]. Anti-Cancer Drugs. 2017 ; 28( 6): 634-644.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1097/cad.0000000000000504
Vancouver
Borges KS, Andrade AF, Silveira V da S, Marco Antonio DS, Vasconcelos EJR, Antonini SRR, Tone LG, Scrideli CA. The aurora kinase inhibitor AMG 900 increases apoptosis and induces chemosensitivity to anticancer drugs in the NCI-H295 adrenocortical carcinoma cell line [Internet]. Anti-Cancer Drugs. 2017 ; 28( 6): 634-644.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1097/cad.0000000000000504
Artigo de periodico
The histone deacetylase inhibitor PCI-24781 as a putative radiosensitizer in pediatric glioblastoma cell lines (2016)
Andrade, Pamela Viani de; Andrade, Augusto Faria; Queiroz, Rosane Gomes de Paula; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga; Valera, Elvis Terci
Source: Cancer Cell International. Unidade: FMRP
Subjects: EPIGÊNESE GENÉTICA, SISTEMA NERVOSO CENTRAL, NEOPLASIAS DO SISTEMA NERVOSO, RADIOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANDRADE, Pamela Viani de et al. The histone deacetylase inhibitor PCI-24781 as a putative radiosensitizer in pediatric glioblastoma cell lines. Cancer Cell International, v. 16, 2016Tradução . . Disponível em: https://doi.org/10.1186/s12935-016-0306-5. Acesso em: 13 nov. 2024.
APA
Andrade, P. V. de, Andrade, A. F., Queiroz, R. G. de P., Scrideli, C. A., Tone, L. G., & Valera, E. T. (2016). The histone deacetylase inhibitor PCI-24781 as a putative radiosensitizer in pediatric glioblastoma cell lines. Cancer Cell International, 16. doi:10.1186/s12935-016-0306-5
NLM
Andrade PV de, Andrade AF, Queiroz RG de P, Scrideli CA, Tone LG, Valera ET. The histone deacetylase inhibitor PCI-24781 as a putative radiosensitizer in pediatric glioblastoma cell lines [Internet]. Cancer Cell International. 2016 ; 16[citado 2024 nov. 13 ] Available from: https://doi.org/10.1186/s12935-016-0306-5
Vancouver
Andrade PV de, Andrade AF, Queiroz RG de P, Scrideli CA, Tone LG, Valera ET. The histone deacetylase inhibitor PCI-24781 as a putative radiosensitizer in pediatric glioblastoma cell lines [Internet]. Cancer Cell International. 2016 ; 16[citado 2024 nov. 13 ] Available from: https://doi.org/10.1186/s12935-016-0306-5
Artigo de periodico
Anticancer activity of 7-epiclusianone, a benzophenone from Garcinia brasiliensis, in glioblastoma (2015)
Sales, Leilane; Pezuk, Julia Alejandra; Borges, Kleiton Silva; Brassesco, María Sol; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga; Santos, Marcelo Henrique dos; Ionta, Marisa; Oliveira, Jaqueline Carvalho de
Source: BMC Complementary and Alternative Medicine. Unidades: FMRP, FFCLRP
Subjects: NEOPLASIAS CEREBRAIS, ANTINEOPLÁSICOS, EXTRATOS (FORMAS FARMACÊUTICAS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SALES, Leilane et al. Anticancer activity of 7-epiclusianone, a benzophenone from Garcinia brasiliensis, in glioblastoma. BMC Complementary and Alternative Medicine, v. 15, 2015Tradução . . Disponível em: https://doi.org/10.1186/s12906-015-0911-1. Acesso em: 13 nov. 2024.
APA
Sales, L., Pezuk, J. A., Borges, K. S., Brassesco, M. S., Scrideli, C. A., Tone, L. G., et al. (2015). Anticancer activity of 7-epiclusianone, a benzophenone from Garcinia brasiliensis, in glioblastoma. BMC Complementary and Alternative Medicine, 15. doi:10.1186/s12906-015-0911-1
NLM
Sales L, Pezuk JA, Borges KS, Brassesco MS, Scrideli CA, Tone LG, Santos MH dos, Ionta M, Oliveira JC de. Anticancer activity of 7-epiclusianone, a benzophenone from Garcinia brasiliensis, in glioblastoma [Internet]. BMC Complementary and Alternative Medicine. 2015 ; 15[citado 2024 nov. 13 ] Available from: https://doi.org/10.1186/s12906-015-0911-1
Vancouver
Sales L, Pezuk JA, Borges KS, Brassesco MS, Scrideli CA, Tone LG, Santos MH dos, Ionta M, Oliveira JC de. Anticancer activity of 7-epiclusianone, a benzophenone from Garcinia brasiliensis, in glioblastoma [Internet]. BMC Complementary and Alternative Medicine. 2015 ; 15[citado 2024 nov. 13 ] Available from: https://doi.org/10.1186/s12906-015-0911-1
Artigo de periodico
Low expression of HLA-DRA, HLA-DPA1, and HLA-DPB1 is associated with poor prognosis in pediatric adrenocortical tumors (ACT) (2014)
Leite, Fabíola A; Lira, Régia C. P; Fedatto, Paola F; Antonini, Sonir Roberto Rauber; Martinelli Junior, Carlos Eduardo; Castro, Margaret de; Neder, Luciano; Ramalho, Leandra Naíra Zambelli; Tucci Júnior, Silvio; Mastelaro, Maria J; Seidinger, Ana L; Cardinalli, Izilda A; Yunes, José A; Brandalise, Silvia R; Tone, Luiz Gonzaga; Scrideli, Carlos Alberto
Source: Pediatric Blood and Cancer. Unidade: FMRP
Subjects: NEOPLASIAS DO CÓRTEX SUPRARRENAL, CRIANÇAS, PROGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEITE, Fabíola A et al. Low expression of HLA-DRA, HLA-DPA1, and HLA-DPB1 is associated with poor prognosis in pediatric adrenocortical tumors (ACT). Pediatric Blood and Cancer, v. 61, n. 11, p. 1940-1948, 2014Tradução . . Disponível em: https://doi.org/10.1002/pbc.25118. Acesso em: 13 nov. 2024.
APA
Leite, F. A., Lira, R. C. P., Fedatto, P. F., Antonini, S. R. R., Martinelli Junior, C. E., Castro, M. de, et al. (2014). Low expression of HLA-DRA, HLA-DPA1, and HLA-DPB1 is associated with poor prognosis in pediatric adrenocortical tumors (ACT). Pediatric Blood and Cancer, 61( 11), 1940-1948. doi:10.1002/pbc.25118
NLM
Leite FA, Lira RCP, Fedatto PF, Antonini SRR, Martinelli Junior CE, Castro M de, Neder L, Ramalho LNZ, Tucci Júnior S, Mastelaro MJ, Seidinger AL, Cardinalli IA, Yunes JA, Brandalise SR, Tone LG, Scrideli CA. Low expression of HLA-DRA, HLA-DPA1, and HLA-DPB1 is associated with poor prognosis in pediatric adrenocortical tumors (ACT) [Internet]. Pediatric Blood and Cancer. 2014 ; 61( 11): 1940-1948.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1002/pbc.25118
Vancouver
Leite FA, Lira RCP, Fedatto PF, Antonini SRR, Martinelli Junior CE, Castro M de, Neder L, Ramalho LNZ, Tucci Júnior S, Mastelaro MJ, Seidinger AL, Cardinalli IA, Yunes JA, Brandalise SR, Tone LG, Scrideli CA. Low expression of HLA-DRA, HLA-DPA1, and HLA-DPB1 is associated with poor prognosis in pediatric adrenocortical tumors (ACT) [Internet]. Pediatric Blood and Cancer. 2014 ; 61( 11): 1940-1948.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1002/pbc.25118
Artigo de periodico
Inhibition of Aurora Kinases enhances chemosensitivity to temozolomide and causes radiosensitization in glioblastoma cells (2012)
Borges, Kleiton Silva; Gamero, Angel Mauricio Castro; Moreno, Daniel Antunes; Silveira, Vanessa da Silva; Brassesco, Maria Sol; Queiroz, Rosane Gomes de Paula; Oliveira, Harley Francisco de; Carlotti Júnior, Carlos Gilberto; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga
Source: Journal of Cancer Research and Clinical Oncology. Unidade: FMRP
Subjects: NEOPLASIAS CEREBRAIS, PROTEÍNAS QUINASES, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORGES, Kleiton Silva et al. Inhibition of Aurora Kinases enhances chemosensitivity to temozolomide and causes radiosensitization in glioblastoma cells. Journal of Cancer Research and Clinical Oncology, v. 138, n. 3, p. 405-414, 2012Tradução . . Disponível em: https://doi.org/10.1007/s00432-011-1111-0. Acesso em: 13 nov. 2024.
APA
Borges, K. S., Gamero, A. M. C., Moreno, D. A., Silveira, V. da S., Brassesco, M. S., Queiroz, R. G. de P., et al. (2012). Inhibition of Aurora Kinases enhances chemosensitivity to temozolomide and causes radiosensitization in glioblastoma cells. Journal of Cancer Research and Clinical Oncology, 138( 3), 405-414. doi:10.1007/s00432-011-1111-0
NLM
Borges KS, Gamero AMC, Moreno DA, Silveira V da S, Brassesco MS, Queiroz RG de P, Oliveira HF de, Carlotti Júnior CG, Scrideli CA, Tone LG. Inhibition of Aurora Kinases enhances chemosensitivity to temozolomide and causes radiosensitization in glioblastoma cells [Internet]. Journal of Cancer Research and Clinical Oncology. 2012 ; 138( 3): 405-414.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1007/s00432-011-1111-0
Vancouver
Borges KS, Gamero AMC, Moreno DA, Silveira V da S, Brassesco MS, Queiroz RG de P, Oliveira HF de, Carlotti Júnior CG, Scrideli CA, Tone LG. Inhibition of Aurora Kinases enhances chemosensitivity to temozolomide and causes radiosensitization in glioblastoma cells [Internet]. Journal of Cancer Research and Clinical Oncology. 2012 ; 138( 3): 405-414.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1007/s00432-011-1111-0
Artigo de periodico
Minimal residual disease in cerebrospinal fluid at diagnosis: a more intensive treatment protocol was able to eliminate the adverse prognosis in children with acute lymphoblastic leukemia (2012)
Biojone, Estefânia; Queiroz, Rosane Gomes de Paula; Valera, Elvis Terci; Odashima, Newton Satoro; Takayanagui, Osvaldo Massaiti; Viana, Marcos Borato; Tone, Luiz Gonzaga; Scrideli, Carlos Alberto
Source: Leukemia & Lymphoma. Unidade: FMRP
Subjects: LEUCEMIA (TRATAMENTO), CRIANÇAS, LÍQUIDO CEFALORRAQUIDIANO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BIOJONE, Estefânia et al. Minimal residual disease in cerebrospinal fluid at diagnosis: a more intensive treatment protocol was able to eliminate the adverse prognosis in children with acute lymphoblastic leukemia. Leukemia & Lymphoma, v. 53, n. 1, p. 89-95, 2012Tradução . . Disponível em: https://doi.org/10.3109/10428194.2011.606939. Acesso em: 13 nov. 2024.
APA
Biojone, E., Queiroz, R. G. de P., Valera, E. T., Odashima, N. S., Takayanagui, O. M., Viana, M. B., et al. (2012). Minimal residual disease in cerebrospinal fluid at diagnosis: a more intensive treatment protocol was able to eliminate the adverse prognosis in children with acute lymphoblastic leukemia. Leukemia & Lymphoma, 53( 1), 89-95. doi:10.3109/10428194.2011.606939
NLM
Biojone E, Queiroz RG de P, Valera ET, Odashima NS, Takayanagui OM, Viana MB, Tone LG, Scrideli CA. Minimal residual disease in cerebrospinal fluid at diagnosis: a more intensive treatment protocol was able to eliminate the adverse prognosis in children with acute lymphoblastic leukemia [Internet]. Leukemia & Lymphoma. 2012 ; 53( 1): 89-95.[citado 2024 nov. 13 ] Available from: https://doi.org/10.3109/10428194.2011.606939
Vancouver
Biojone E, Queiroz RG de P, Valera ET, Odashima NS, Takayanagui OM, Viana MB, Tone LG, Scrideli CA. Minimal residual disease in cerebrospinal fluid at diagnosis: a more intensive treatment protocol was able to eliminate the adverse prognosis in children with acute lymphoblastic leukemia [Internet]. Leukemia & Lymphoma. 2012 ; 53( 1): 89-95.[citado 2024 nov. 13 ] Available from: https://doi.org/10.3109/10428194.2011.606939
Artigo de periodico
Are patients with encephalocraniocutaneous lipomatosis at increased risk of developing low-grade gliomas? (2012)
Valera, Elvis Terci; Brassesco, Maria Sol; Scrideli, Carlos Alberto; Barros, Marcus Vinicius de Castro; Santos, Antônio Carlos dos; Oliveira, Ricardo Santos de; Machado, Hélio Rubens; Tone, Luiz Gonzaga
Source: Child's Nervous System. Unidade: FMRP
Subjects: NEOPLASIAS CEREBRAIS, PEDIATRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VALERA, Elvis Terci et al. Are patients with encephalocraniocutaneous lipomatosis at increased risk of developing low-grade gliomas?. Child's Nervous System, v. 28, n. 1, p. 19-22, 2012Tradução . . Disponível em: https://doi.org/10.1007/s00381-011-1601-z. Acesso em: 13 nov. 2024.
APA
Valera, E. T., Brassesco, M. S., Scrideli, C. A., Barros, M. V. de C., Santos, A. C. dos, Oliveira, R. S. de, et al. (2012). Are patients with encephalocraniocutaneous lipomatosis at increased risk of developing low-grade gliomas? Child's Nervous System, 28( 1), 19-22. doi:10.1007/s00381-011-1601-z
NLM
Valera ET, Brassesco MS, Scrideli CA, Barros MV de C, Santos AC dos, Oliveira RS de, Machado HR, Tone LG. Are patients with encephalocraniocutaneous lipomatosis at increased risk of developing low-grade gliomas? [Internet]. Child's Nervous System. 2012 ; 28( 1): 19-22.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1007/s00381-011-1601-z
Vancouver
Valera ET, Brassesco MS, Scrideli CA, Barros MV de C, Santos AC dos, Oliveira RS de, Machado HR, Tone LG. Are patients with encephalocraniocutaneous lipomatosis at increased risk of developing low-grade gliomas? [Internet]. Child's Nervous System. 2012 ; 28( 1): 19-22.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1007/s00381-011-1601-z
Artigo de periodico
Expression profile of apoptosis-related genes in childhood adrenocortical tumors: low level of expression of BCL2 and TNF genes suggests a poor prognosis (2012)
Lorea, Cecília Fernandes; Moreno, Daniel Antunes; Borges, Kleiton Silva; Martinelli Junior, Carlos Eduardo; Antonini, Sonir Roberto Rauber; Castro, Margaret de; Tucci Júnior, Silvio; Neder, Luciano; Ramalho, Leandra Naíra Zambelli; Cardinalli, Izilda; Seidinger, Ana Luiza; Mastellaro, Maria José; Yunes, Jose Andres; Brandalise, Silvia Regina; Tone, Luiz Gonzaga; Scrideli, Carlos Alberto
Source: European journal of Endocrinology. Unidade: FMRP
Subjects: APOPTOSE, CRIANÇAS, NEOPLASIAS DAS GLÂNDULAS SUPRARRENAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOREA, Cecília Fernandes et al. Expression profile of apoptosis-related genes in childhood adrenocortical tumors: low level of expression of BCL2 and TNF genes suggests a poor prognosis. European journal of Endocrinology, v. 167, n. 12, p. 199-208, 2012Tradução . . Disponível em: https://doi.org/10.1530/EJE-12-0183. Acesso em: 13 nov. 2024.
APA
Lorea, C. F., Moreno, D. A., Borges, K. S., Martinelli Junior, C. E., Antonini, S. R. R., Castro, M. de, et al. (2012). Expression profile of apoptosis-related genes in childhood adrenocortical tumors: low level of expression of BCL2 and TNF genes suggests a poor prognosis. European journal of Endocrinology, 167( 12), 199-208. doi:10.1530/EJE-12-0183
NLM
Lorea CF, Moreno DA, Borges KS, Martinelli Junior CE, Antonini SRR, Castro M de, Tucci Júnior S, Neder L, Ramalho LNZ, Cardinalli I, Seidinger AL, Mastellaro MJ, Yunes JA, Brandalise SR, Tone LG, Scrideli CA. Expression profile of apoptosis-related genes in childhood adrenocortical tumors: low level of expression of BCL2 and TNF genes suggests a poor prognosis [Internet]. European journal of Endocrinology. 2012 ; 167( 12): 199-208.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1530/EJE-12-0183
Vancouver
Lorea CF, Moreno DA, Borges KS, Martinelli Junior CE, Antonini SRR, Castro M de, Tucci Júnior S, Neder L, Ramalho LNZ, Cardinalli I, Seidinger AL, Mastellaro MJ, Yunes JA, Brandalise SR, Tone LG, Scrideli CA. Expression profile of apoptosis-related genes in childhood adrenocortical tumors: low level of expression of BCL2 and TNF genes suggests a poor prognosis [Internet]. European journal of Endocrinology. 2012 ; 167( 12): 199-208.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1530/EJE-12-0183
Artigo de periodico
Low mRNA expression of the apoptosis-related genes CASP3, CASP8, and FAS is associated with low induction treatment response in childhood acute lymphoblastic leukemia (ALL) (2011)
Mata, Juliana França da; Silveira, Vanessa da Silva; Mateo, Elvis Cristian Cueva; Cortez, Maria Angélica Abdalla de Freitas; Queiroz, Rosane Gomes de Paula; Yunes, Jose Andres; Lee, Maria Lúcia de Martino; Toledo, Silvia Regina Caminada de; Petrilli, Antônio Sérgio; Brandalise, Silvia Regina; Tone, Luiz Gonzaga; Scrideli, Carlos Alberto
Source: Pediatric Blood & Cancer. Unidade: FMRP
Subjects: APOPTOSE, CRIANÇAS, LEUCEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MATA, Juliana França da et al. Low mRNA expression of the apoptosis-related genes CASP3, CASP8, and FAS is associated with low induction treatment response in childhood acute lymphoblastic leukemia (ALL). Pediatric Blood & Cancer, v. 55, n. 1, p. 100-107, 2011Tradução . . Disponível em: https://doi.org/10.1002/pbc.22463. Acesso em: 13 nov. 2024.
APA
Mata, J. F. da, Silveira, V. da S., Mateo, E. C. C., Cortez, M. A. A. de F., Queiroz, R. G. de P., Yunes, J. A., et al. (2011). Low mRNA expression of the apoptosis-related genes CASP3, CASP8, and FAS is associated with low induction treatment response in childhood acute lymphoblastic leukemia (ALL). Pediatric Blood & Cancer, 55( 1), 100-107. doi:10.1002/pbc.22463
NLM
Mata JF da, Silveira V da S, Mateo ECC, Cortez MAA de F, Queiroz RG de P, Yunes JA, Lee ML de M, Toledo SRC de, Petrilli AS, Brandalise SR, Tone LG, Scrideli CA. Low mRNA expression of the apoptosis-related genes CASP3, CASP8, and FAS is associated with low induction treatment response in childhood acute lymphoblastic leukemia (ALL) [Internet]. Pediatric Blood & Cancer. 2011 ; 55( 1): 100-107.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1002/pbc.22463
Vancouver
Mata JF da, Silveira V da S, Mateo ECC, Cortez MAA de F, Queiroz RG de P, Yunes JA, Lee ML de M, Toledo SRC de, Petrilli AS, Brandalise SR, Tone LG, Scrideli CA. Low mRNA expression of the apoptosis-related genes CASP3, CASP8, and FAS is associated with low induction treatment response in childhood acute lymphoblastic leukemia (ALL) [Internet]. Pediatric Blood & Cancer. 2011 ; 55( 1): 100-107.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1002/pbc.22463
Artigo de periodico
Exposure to magnetic fileds and childhood acute lymphocytic leukemia in São Paulo, Brazil (2011)
Wunsch Filho, Victor; Pelissari, Daniele Maria; Barbieri, Flavio Eitor; Sant'anna, Leonel; Oliveira, Claudia Teresa de; Mata, Juliana França da; Tone, Luiz Gonzaga; Lee, Maria Lúcia de Martino; Andrea, Maria Lydia Mello de; Bruniera, Paula; Epelman, Sidnei; Odone Filho, Vicente; Kheifets, Leeka
Source: Cancer Epidemiology. Unidades: FSP, FMRP, FM
Subjects: CAMPO ELETROMAGNÉTICO, LEUCEMIA, CRIANÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WUNSCH FILHO, Victor et al. Exposure to magnetic fileds and childhood acute lymphocytic leukemia in São Paulo, Brazil. Cancer Epidemiology, v. 35, n. 6, p. 534-539, 2011Tradução . . Disponível em: https://doi.org/10.1016/j.canep.2011.05.008. Acesso em: 13 nov. 2024.
APA
Wunsch Filho, V., Pelissari, D. M., Barbieri, F. E., Sant'anna, L., Oliveira, C. T. de, Mata, J. F. da, et al. (2011). Exposure to magnetic fileds and childhood acute lymphocytic leukemia in São Paulo, Brazil. Cancer Epidemiology, 35( 6), 534-539. doi:10.1016/j.canep.2011.05.008
NLM
Wunsch Filho V, Pelissari DM, Barbieri FE, Sant'anna L, Oliveira CT de, Mata JF da, Tone LG, Lee ML de M, Andrea MLM de, Bruniera P, Epelman S, Odone Filho V, Kheifets L. Exposure to magnetic fileds and childhood acute lymphocytic leukemia in São Paulo, Brazil [Internet]. Cancer Epidemiology. 2011 ; 35( 6): 534-539.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.canep.2011.05.008
Vancouver
Wunsch Filho V, Pelissari DM, Barbieri FE, Sant'anna L, Oliveira CT de, Mata JF da, Tone LG, Lee ML de M, Andrea MLM de, Bruniera P, Epelman S, Odone Filho V, Kheifets L. Exposure to magnetic fileds and childhood acute lymphocytic leukemia in São Paulo, Brazil [Internet]. Cancer Epidemiology. 2011 ; 35( 6): 534-539.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.canep.2011.05.008

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Countries/Territories

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration